Category Archives: Pricing

Time to put a stop to the abuse of orphan drug regulation- the latest scandal

10th Jan 2019, New Delhi Source: Medicines Law and Policy Today, the Dutch Medical Journal (Nederlands Tijdschrift voor Geneeskunde) reported on the case of lutetium-octreotaat, a cancer drug developed by researchers in the Dutch Erasmus medical centre in Rotterdam. For … Continue reading

Posted in Access to Medecines, Cancer, Innovation, orphan drug, Patent, Price hikes, Pricing | Leave a comment

Who’s paying for lunch? Here’s exactly how drug companies wine and dine our doctor

23rd Nov 2018, New Delhi Source: The Conversation In June 2015, 24 Australian cancer specialists flew to Chicago to attend a five-day conference. Drug giant Amgen funded the trip, including registration, transfers and wining and dining. It cost almost A$270,000. … Continue reading

Posted in Access to Medecines, Pharmaceutical Benefits Scheme | Leave a comment

WHO: Proposed work program on “fair price” undermines affordability of medicines

Source: The Third World Network | May 21, 2018 by KM Gopakumar Geneva:  The proposed work program on fair price raises concerns on affordability of medicines. The document was prepared by the Secretariat of the World Health Organization (WHO)for the … Continue reading

Posted in Access to Medecines, Drug prices, Pricing, TRIPS, TRIPS flexibilities, Uncategorized | Leave a comment

To Lower Drug Costs at Home, Trump Wants Higher Prices Abroad

Source: The New York Times | May 9, 2018 WASHINGTON — President Trump, poised on Friday to unveil his strategy to lower prescription drug prices, has an idea that may not be so popular abroad: Bring down costs at home … Continue reading

Posted in Access to Medecines, Drug prices, Pricing, Uncategorized | Leave a comment

KHN launches “Pre$cription for Power,” a groundbreaking database to expose Big Pharma’s ties to patient groups.

Source: Kaiser Health News Pharmaceutical companies gave at least $116 million to patient advocacy groups in a single year, reveals a new database logging 12,000 donations from large publicly traded drugmakers to such organizations. Even as these patient groups grow in number … Continue reading

Posted in Bad Pharma, Big Pharma myths, Drug prices, Price hikes, Price Negotiations, Uncategorized | Leave a comment

Why do new medicines cost so much, and what can we do about it? The cost of new drugs is putting increasing pressure on people in both rich and poor countries. Sarah Boseley explains why it’s a burning issue

Source: The Guardian|April 09, 2018 Why does it matter what medicines cost? If you are lucky enough to live in a country with comprehensive state-funded healthcare, such as the UK, you probably have no idea how much medicines really cost. … Continue reading

Posted in Access to Medecines, Access to Medicins, Drug prices, IP Rights, Patent, Pricing, R&D | Leave a comment

USTR targets India on Price Control of Medical devices

10th April 2018 As you may be aware the United States Trade Representative (USTR) puts pressure on developing countries on behalf of their pharmaceutical industry , which has had a major chilling effect on the use of the compulsory licensing … Continue reading

Posted in Access to Medecines, Pricing, USTR | Leave a comment